Does Aktis Oncology have an economic moat?
Likely
Aktis Oncology earns 73.8% a year on the money invested in it and keeps 89% of every sale after production costs, the numbers of a business competitors struggle to copy.
The numbers behind it
Return on invested capital, average of recent years73.8%
Return on invested capital, latest year-10.1%
Gross margin89.2%Share of each sale left after production costs
Net margin-980.9%
How we decide
A moat shows up in the numbers as high returns that last. We call it likely when the average return on invested capital over recent years is at least 15% and the gross margin at least 40%, and possible from 10%. The numbers can't show where a moat comes from (brand, network, patents), only that one seems to exist.
More questions about Aktis Oncology
Data as of Nov 13, 2026.